Christopher M Pieczonka (Christopher Pieczonka)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Bone Regeneration

Prostate Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Emmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, Lawrence Ivan Karsh, David I Quinn, Jason M Hafron, Helen M Wilfehrt, Matthew Harmon, Nadeem A Sheikh, Neal D Shore, Daniel P Petrylak
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mark C Markowski, Ronald Tutrone, Christopher M Pieczonka, K Gary Barnette, Robert H Getzenberg, Domingo Rodriguez, Mitchell S Steiner, Daniel R Saltzstein, Mario A Eisenberger, Emmanuel S Antonarakis
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Neal D Shore, Charles G Drake, Daniel W Lin, Charles J Ryan, Kelly L Stratton, Curtis Dunshee, Lawrence Ivan Karsh, Sanjeev Kaul, Ken Kernen, Christopher M Pieczonka, Paul Sieber, Christopher Stewart, Michael Williams, Raoul S Concepcion
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians. The Prostate 80 (14) (2020)
Arif Hussain, Abhishek Tripathi, Christopher M Pieczonka, Diane Cope, Andrea McNatty, Christopher Logothetis, Theresa Guise
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases 24 (2) (2020)